NewLink Genetics Stock Forecast, Price & News

NewLink Genetics (NASDAQ:NLNK) Frequently Asked Questions

What stocks does MarketBeat like better than NewLink Genetics?

Wall Street analysts have given NewLink Genetics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NewLink Genetics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were NewLink Genetics' earnings last quarter?

NewLink Genetics Corp (NASDAQ:NLNK) released its earnings results on Wednesday, November, 6th. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.27). The biotechnology company earned $0.25 million during the quarter. NewLink Genetics had a negative trailing twelve-month return on equity of 41.50% and a negative net margin of 4,592.84%.
View NewLink Genetics' earnings history.

Who are NewLink Genetics' key executives?

NewLink Genetics' management team includes the following people:

• Dr. Charles J. Link Jr., Co-Founder, Chairman, CEO & Chief Scientific Officer (Age 60)
• Mr. Nicholas N. Vahanian, Co-Founder, Pres, Chief Medical Officer & Director (Age 52)
• Dr. Eugene P. Kennedy M.D., FACS, Chief Medical Officer (Age 50)
• Mr. Brian Wiley, Chief Commercial Officer (Age 51)
• Mr. Carl W. Langren, CFO & Principal Accounting Officer (Age 64)

Who are some of NewLink Genetics' key competitors?

Some companies that are related to NewLink Genetics include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alnylam Pharmaceuticals (ALNY), Exact Sciences (EXAS), Repligen (RGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Novavax (NVAX), Neurocrine Biosciences (NBIX), United Therapeutics (UTHR) and Exelixis (EXEL).
View all of NLNK's competitors.

What other stocks do shareholders of NewLink Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NewLink Genetics investors own include Inovio Pharmaceuticals (INO), Arbutus Biopharma (ABUS), OPKO Health (OPK), Novavax (NVAX), SunPower (SPWR), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT), Alibaba Group (BABA), Cara Therapeutics (CARA) and Gilead Sciences (GILD).

What is NewLink Genetics' stock symbol?

NewLink Genetics trades on the NASDAQ under the ticker symbol "NLNK."

What is NewLink Genetics' stock price today?

One share of NLNK stock can currently be purchased for approximately $9.14.

How much money does NewLink Genetics make?

NewLink Genetics has a market capitalization of $341.18 million and generates $940,000.00 in revenue each year. The biotechnology company earns $-42.99 million in net income (profit) each year or ($1.03) on an earnings per share basis.

How many employees does NewLink Genetics have?

NewLink Genetics employs 55 workers across the globe.

What is NewLink Genetics' official website?

The official website for NewLink Genetics is www.newlinkgenetics.com.

Where are NewLink Genetics' headquarters?

NewLink Genetics is headquartered at 2503 SOUTH LOOP DRIVE, AMES IA, 50010.

How can I contact NewLink Genetics?

NewLink Genetics' mailing address is 2503 SOUTH LOOP DRIVE, AMES IA, 50010. The biotechnology company can be reached via phone at 515-296-5555 or via email at [email protected].